Dr. Eugene Hwang, MD
Claim this profileChildren's National Medical Center
Expert in Brain Tumor
Expert in Cerebral Gliomas
21 reported clinical trials
32 drugs studied
About Eugene Hwang, MD
Education:
- Obtained MD from the University of California, San Francisco School of Medicine in 2006.
- Completed Residency in Pediatrics at Children's National Medical Center in 2009.
- Finished Fellowship in Pediatric Infectious Diseases at Children's National Medical Center in 2012.
Experience:
- Associate Professor of Pediatrics and Director of the Division of Pediatric Infectious Diseases at Children's National Medical Center.
Area of expertise
1Brain Tumor
Global LeaderStage IV
NTRK positive
Stage III
2Cerebral Gliomas
Global LeaderStage IV
NTRK positive
Stage III
Affiliated Hospitals
Clinical Trials Eugene Hwang, MD is currently running
Ribociclib + Everolimus
for Brain Tumors
This trial is testing whether the combination of ribociclib and everolimus can help children and young adults with aggressive brain tumors live longer. Everolimus is a medication that has been approved for treating various cancers. These drugs are taken by mouth and work by stopping cancer cells from growing. The study focuses on patients whose tumors have specific genetic changes that make them hard to treat with standard therapies.
Recruiting1 award Phase 2
Adoptive Cellular Therapy
for Pediatric Brain Tumors
This is an open-label phase 1 safety and feasibility study that will employ multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T) directed against proteogenomically determined personalized tumor-specific antigens (TSA) derived from a patient's primary brain tumor tissues. Young patients with embryonal central nervous system (CNS) malignancies typically are unable to receive irradiation due to significant adverse effects and are treated with intensive chemotherapy followed by autologous stem cell rescue; however, despite intensive therapy, many of these patients relapse. In this study, individualized TSA-T cells will be generated against proteogenomically determined tumor-specific antigens after standard of care treatment in children less than 5 years of age with embryonal brain tumors. Correlative biological studies will measure clinical anti-tumor, immunological and biomarker effects.
Recruiting1 award Phase 15 criteria
More about Eugene Hwang, MD
Clinical Trial Related4 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Eugene Hwang, MD has experience with
- TAA-T
- Multi-tumor Antigen Specific Cytotoxic T Lymphocytes (TSA-T)
- Cisplatin
- Cyclophosphamide
- Vismodegib
- Vincristine
Breakdown of trials Eugene Hwang, MD has run
Brain Tumor
Cerebral Gliomas
Medulloblastoma
Brain Cancer
Diffuse Intrinsic Pontine Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eugene Hwang, MD specialize in?
Eugene Hwang, MD focuses on Brain Tumor and Cerebral Gliomas. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are NTRK positive.
Is Eugene Hwang, MD currently recruiting for clinical trials?
Yes, Eugene Hwang, MD is currently recruiting for 9 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Eugene Hwang, MD has studied deeply?
Yes, Eugene Hwang, MD has studied treatments such as TAA-T, Multi-tumor antigen specific cytotoxic T lymphocytes (TSA-T), Cisplatin.
What is the best way to schedule an appointment with Eugene Hwang, MD?
Apply for one of the trials that Eugene Hwang, MD is conducting.
What is the office address of Eugene Hwang, MD?
The office of Eugene Hwang, MD is located at: Children's National Medical Center, Washington, District of Columbia 20010 United States. This is the address for their practice at the Children's National Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.